Specimen Collection Cards Market - By Product (Cotton & Cellulose-based, Fiber-based), Specimen (Blood, Saliva, Urine), Application (Infectious Disease Testing, Newborn Screening), End-use

Description

List of Tables

Specimen Collection Cards Market is estimated to observe 5% CAGR from 2023 to 2032, driven by increasing emphasis on efficient diagnostic procedures. Specimen collection cards, with their ability to simplify sample collection, transport, and storage, contribute to streamlined diagnostic processes. This is particularly crucial in healthcare settings where quick and accurate sample collection is essential for timely diagnosis and treatment.

The product finds application in preserving DNA, RNA, or proteins for molecular testing, making it indispensable in research and diagnostic laboratories. The growing adoption of molecular diagnostic techniques for various diseases fuels the market demand. In June 2022, GenTegra LLC, a leader of complete sample protection for biological research, launched RNAdvantage, the latest RNA stabilization products in their suite. With this launch, GenTegra products can stabilize and protect valuable RNA in fresh tissue samples and purified liquid RNA.

The worldwide specimen collection cards industry is segmented based on product type, specimen type, application, end-use, and region.

Fiber-based segment is anticipated to gain momentum and grow at a strong CAGR through 2032, owing to its advantages in sample preservation and transportation. These cards provide a stable environment for specimen storage, preventing degradation of nucleic acids and ensuring the integrity of biological samples. Additionally, the eco-friendly nature of fiber-based materials aligns with the increasing emphasis on sustainable and biodegradable products, contributing to the product demand.

Urine segment will record notable growth during 2023 and 2032, due to the convenience and non-invasive nature in sample collection. The cards designed for urine samples provide a user-friendly method for collecting and preserving specimens without the need for specialized equipment or invasive procedures. This simplicity makes them particularly attractive in various diagnostic applications, including drug testing, pregnancy testing, and disease monitoring. The ease of use, coupled with the ability to stabilize urine samples for extended periods, will favor the usage of specimen collection cards.

Europe specimen collection cards industry size will witness significant growth throughout 2023 and 2032, backed by the increasing prevalence of chronic diseases and the rising focus on preventive healthcare. The advancements in personalized medicine and molecular diagnostics further fuel the product demand, especially in applications including genomics and infectious disease testing. Stringent regulations and quality standards in the European healthcare sector underscore the importance of reliable and standardized sample collection methods, stimulating the regional market growth.

Product Code: 7536

Chapter 1 Methodology & Scope

1.1 Market scope & definition
1.2 Base estimates & workings
1.3 Forecast calculations
1.4 Data Sources
- 1.4.1 Primary
- 1.4.2 Secondary
  - 1.4.2.1 Paid sources
  - 1.4.2.2 Unpaid sources

Chapter 2 Executive Summary

2.1 Global specimen collection cards market 360 degree synopsis, 2018 - 2032
- 2.1.1 Regional trends
- 2.1.2 Product type trends
- 2.1.3 Specimen type trends
- 2.1.4 Application trends
- 2.1.5 End-use trends

Chapter 3 Specimen Collection Cards Industry Insights

3.1 COVID- 19 impact analysis
3.2 Industry ecosystem analysis
3.3 Technology landscape
3.4 Regulatory landscape
3.5 Industry impact forces
- 3.5.1 Growth drivers
  - 3.5.1.1 Increased demand for molecular diagnostics
  - 3.5.1.2 Technological advancements in specimen collection cards
  - 3.5.1.3 Rising incidence of infectious diseases
  - 3.5.1.4 Surge in point-of-care testing devices
- 3.5.2 Industry pitfalls & challenges
  - 3.5.2.1 Concerns associated with sample contamination
  - 3.5.2.2 Stringent regulatory scenario
3.6 Growth potential analysis
- 3.6.1 By product type
- 3.6.2 By specimen type
- 3.6.3 By application
- 3.6.4 By end-use
3.7 Porter's analysis
3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

4.1 Introduction
4.2 Company market share analysis, 2022
4.3 Competitive analysis of major market players, 2022
4.4 Competitive positioning matrix, 2022
4.5 Strategic outlook matrix, 2022

Chapter 5 Specimen Collection Cards Market Size and Forecast, By Product Type, 2018-2032 (USD Million)

5.1 Key trends, by product type
5.2 Cotton & cellulose-based
5.3 Fiber-based
5.4 Other product types

Chapter 6 Specimen Collection Cards Market Size and Forecast, By Specimen Type, 2018-2032 (USD Million)

6.1 Key trends, by specimen type
6.2 Blood
6.3 Saliva
6.4 Urine
6.5 Buccal cell
6.6 Other specimen types

Chapter 7 Specimen Collection Cards Market Size and Forecast, By Application, 2018-2032 (USD Million)

7.1 Key trends, by application
7.2 New born screening (NBS)
7.3 Infectious diseases testing
7.4 Therapeutic drug monitoring
7.5 Forensics & research
7.6 Wellbeing/health monitoring
7.7 Other applications

Chapter 8 Specimen Collection Cards Market Size and Forecast, By End-use, 2018-2032 (USD Million)

8.1 Key trends, by end-use
8.2 Hospitals & clinics
8.3 Diagnostics centers
8.4 Other end users

Chapter 9 Specimen Collection Cards Market Size and Forecast, By Region, 2018-2032 (USD Million)

9.1 Key trends, by region
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Italy
- 9.3.5 Spain
- 9.3.6 Rest of Europe
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Rest of Latin America
9.6 Middle East & Africa
- 9.6.1 Saudi Arabia
- 9.6.2 South Africa
- 9.6.3 UAE
- 9.6.4 Rest of Middle East & Africa

Chapter 10 Company Profiles

10.1 Ahlstrom-Munksjö
10.2 GenoTech Innovations Inc.
10.3 Biocare Solutions Ltd.
10.4 PolyTech Research Solutions
10.5 QIAGEN
10.6 CENTOGENE N.V.
10.7 Innovate Diagnostics Technologies
10.8 PerkinElmer Inc.
10.9 Cytiva (Danaher Corporation)
10.10 ARCHIMED Life Science GmbH
10.11 FortiusBio
10.12 Eastern Business Forms, Inc.
10.13 DBS System SA
10.14 GenTegra LLC